Hegde, Pranay S.
Andrew, Georgia
Gui, Gege
Ravindra, Niveditha https://orcid.org/0000-0002-2550-493X
Mukherjee, Devdeep
Wong, Zoƫ C. https://orcid.org/0000-0001-6006-1233
Auletta, Jeffery J. https://orcid.org/0000-0002-1515-2141
El Chaer, Firas
Corner, Adam
Devine, Steven M. https://orcid.org/0000-0001-7731-759X
Jimenez Jimenez, Antonio Martin https://orcid.org/0000-0003-2817-6836
De Lima, Marcos J. G. https://orcid.org/0000-0002-8568-4522
Litzow, Mark R. https://orcid.org/0000-0002-9816-6302
Kebriaei, Partow https://orcid.org/0000-0002-8607-9404
Saber, Wael
Spellman, Stephen R. https://orcid.org/0000-0002-7271-8252
Zeger, Scott L.
Page, Kristin M.
Dillon, Laura W. https://orcid.org/0000-0002-4877-9354
Hourigan, Christopher S.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (1ZIAHL006163)
FNIH Biomarkers Consortium project MRD in AML
Article History
Received: 23 July 2024
Revised: 9 October 2024
Accepted: 10 October 2024
First Online: 18 October 2024
Competing interests
: CSH: The National Heart, Lung, and Blood Institute receives research funding for the laboratory of CSH from the Foundation of the NIH AML MRD Biomarkers Consortium. Auletta: Advisory Committee: AscellaHealth and Takeda. FEC: Consultant: SPD Oncology, Amgen, Association of Community Cancer Centers; Clinical Trial Grant Support (PI) to the University of Virginia: Amgen, BMS, Celgene, SPD Oncology, Sanofi, Bristol Myers Squibb, FibroGen, PharmaEssentia, BioSight, MEI Pharma, Novartis, Arog pharmaceuticals; Travel grant: DAVA Oncology. Corner: Employment: Bio-Rad Laboratories. MJJ: Funding: Abbvie. JGDL: Advisory Board: Pfizer, Bristol Myers Squibb; Data Safety Monitoring Board: Novartis, Abbvie; Research Funding: Miltenyi Biotec. Litzow: Research support: Abbvie, Astellas, Amgen, Actinium, Pluristem, Sanofi; Speakers Bureau: Beigene, Amgen; Data Safety Monitoring Committee: Biosight. Kebriaei: Consultant: Pfizer, Jazz Pharmaceuticals.